作为治疗肝炎病毒感染的新抗病毒策略的CRISPR/Cas9
Ulyana I Bartosh1, Anton S Dome1, Natalya V Zhukova1
1The Institute of Chemical Biology and Fundamental Medicine, Siberian Branch, Russian Academy of Sciences, Novosibirsk 630090, Russia.
International journal of molecular sciences
|January 11, 2024
概括
克里斯普尔/Cas9技术提供了一种新的方法来打击病毒性肝炎,这是一个重要的全球健康问题. 这种基因编辑工具对开发针对甲型,乙型和型肝炎病毒的新疗法充满希望.
科学领域:
- 分子生物学分子生物学
- 肝病学 肝病学是一种肝病学.
- 基因编辑技术的技术
背景情况:
- 病毒性肝炎是由HAV,HBV,HCV,HDV和HEV引起的,每年导致超过100万人的死亡.
- 慢性HBV和HCV感染可能导致肝硬化和肝细胞癌 (HCC).
- 目前用于病毒性肝炎的治疗方法,包括干扰素α和核酸抑制剂,在实现完全治愈和治疗慢性感染方面存在局限性.
研究的目的:
- 审查CRISPR/Cas9基因编辑技术在治疗病毒性肝炎中的应用.
- 探索治疗急性和慢性病毒性肝炎的新药开发策略.
- 总结关于使用CRISPR/Cas系统对抗甲型,乙型和C型肝炎病毒的当前知识.
主要方法:
- 克里斯普尔/卡斯9系统能够对病毒基因组或参与复制的宿主因素进行有针对性的破坏.
- 指导RNA指导Cas9酶在特定的基因组部位创建双链DNA断裂.
- 审查关于CRISPR/Cas应用在A型肝炎病毒 (HAV),B型肝炎病毒 (HBV) 和C型肝炎病毒 (HCV) 上的现有研究.
主要成果:
- CRISPR/Cas9技术为抗病毒治疗策略提供了一个多功能平台.
- 精确准病毒遗传物质或宿主细胞机制的潜力对于病毒复制至关重要.
- 突出了针对具有挑战性的病毒性肝炎感染的药物开发的创新方法.
结论:
- 克里斯普尔/Cas9代表了开发新型病毒性肝炎治疗方法的突破性进展.
- 这项技术对治疗急性和慢性形式的甲型,乙型和乙型肝炎具有前景.
- 对CRISPR/Cas应用的进一步研究对于推进病毒性肝炎治疗至关重要.
相关概念视频
CRISPR
51.1K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
51.1K
CRISPR and crRNAs
17.0K
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
17.0K
Homologous Recombination
50.6K
The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...
50.6K


